160 related articles for article (PubMed ID: 27831763)
21. Incidence and risk factors for radioactive iodine-induced sialadenitis.
Sánchez Barrueco A; González Galán F; Alcalá Rueda I; Santillán Coello JM; Barrio Dorado MP; Villacampa Aubá JM; Escanciano Escanciano M; Llanos Jiménez L; Mahillo Fernández I; Cenjor Español C
Acta Otolaryngol; 2020 Nov; 140(11):959-962. PubMed ID: 32815758
[TBL] [Abstract][Full Text] [Related]
22. Salivary gland function after sialendoscopy for treatment of chronic radioiodine-induced sialadenitis.
Kim YM; Choi JS; Hong SB; Hyun IY; Lim JY
Head Neck; 2016 Jan; 38(1):51-8. PubMed ID: 24995941
[TBL] [Abstract][Full Text] [Related]
23. Prostaglandins as biochemical markers of radiation injury to the salivary glands after iodine-131 therapy?
Rodrigues M; Havlik E; Peskar B; Sinzinger H
Eur J Nucl Med; 1998 Mar; 25(3):265-9. PubMed ID: 9580860
[TBL] [Abstract][Full Text] [Related]
24. Re: does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer?
Lam MG; van Isselt JW
J Nucl Med; 2005 Dec; 46(12):2118; author reply 2118-9. PubMed ID: 16330579
[No Abstract] [Full Text] [Related]
25. Early and late adverse effects of radioiodine for pediatric differentiated thyroid cancer.
Albano D; Bertagna F; Panarotto MB; Giubbini R
Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28436606
[TBL] [Abstract][Full Text] [Related]
26. Late side effects of radioactive iodine on salivary gland function in patients with thyroid cancer.
Almeida JP; Sanabria AE; Lima EN; Kowalski LP
Head Neck; 2011 May; 33(5):686-90. PubMed ID: 21484917
[TBL] [Abstract][Full Text] [Related]
27. Salivary and lacrimal gland dysfunction (sicca syndrome) after radioiodine therapy.
Solans R; Bosch JA; Galofré P; Porta F; Roselló J; Selva-O'Callagan A; Vilardell M
J Nucl Med; 2001 May; 42(5):738-43. PubMed ID: 11337569
[TBL] [Abstract][Full Text] [Related]
28. Sialadenitis following iodine-131 therapy for thyroid carcinoma.
J Nucl Med; 1985 Jul; 26(7):816-7. PubMed ID: 4009293
[No Abstract] [Full Text] [Related]
29. Effect of reserpine on salivary gland radioiodine uptake in thyroid cancer.
Levy HA; Park CH
Clin Nucl Med; 1987 Apr; 12(4):303-7. PubMed ID: 3581610
[TBL] [Abstract][Full Text] [Related]
30. Salivary gland function in thyroid cancer patients with radioiodine administration history.
Krcalova E; Horacek J; Gabalec F; Zak P; Dolezal J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Sep; 164(3):277-283. PubMed ID: 31223135
[TBL] [Abstract][Full Text] [Related]
31. Does vitamin E protect salivary glands from I-131 radiation damage in patients with thyroid cancer?
Fallahi B; Beiki D; Abedi SM; Saghari M; Fard-Esfahani A; Akhzari F; Mokarami B; Eftekhari M
Nucl Med Commun; 2013 Aug; 34(8):777-86. PubMed ID: 23708871
[TBL] [Abstract][Full Text] [Related]
32. Sialochemical and oxidative analyses in radioactive I131-treated patients with thyroid carcinoma.
Ish-Shalom S; Durleshter L; Segal E; Nagler RM
Eur J Endocrinol; 2008 May; 158(5):677-81. PubMed ID: 18426826
[TBL] [Abstract][Full Text] [Related]
33. Salivary evaluation in radioactive I
Daniel FI; Lima LD; Grando LJ; Castro R; Cordeiro EAK; Dos Santos CR
Acta Odontol Scand; 2018 Mar; 76(2):148-152. PubMed ID: 29125000
[TBL] [Abstract][Full Text] [Related]
34. [Quantitative salivary gland scintigraphy--a recommended examination prior to and after radioiodine therapy].
Bohuslavizki KH; Brenner W; Lassmann S; Tinnemeyer S; Kalina S; Clausen M; Henze E
Nuklearmedizin; 1997 Apr; 36(3):103-9. PubMed ID: 9162904
[TBL] [Abstract][Full Text] [Related]
35. Preserving formerly impaired salivary gland function in radioiodine-treated thyroid papillary carcinoma.
Aframian DJ; Nahlieli O; Knopf A; Lukach L; Qawasmeh N; Nadler C
Quintessence Int; 2013 May; 44(5):439-44. PubMed ID: 23479590
[TBL] [Abstract][Full Text] [Related]
36. The influence of saliva flow stimulation on the absorbed radiation dose to the salivary glands during radioiodine therapy of thyroid cancer using 124I PET(/CT) imaging.
Jentzen W; Balschuweit D; Schmitz J; Freudenberg L; Eising E; Hilbel T; Bockisch A; Stahl A
Eur J Nucl Med Mol Imaging; 2010 Dec; 37(12):2298-306. PubMed ID: 20625723
[TBL] [Abstract][Full Text] [Related]
37. Incidence of salivary side effects after radioiodine treatment using a new specifically-designed questionnaire.
Moreddu E; Baumstarck-Barrau K; Gabriel S; Fakhry N; Sebag F; Mundler O; Chossegros C; Taïeb D
Br J Oral Maxillofac Surg; 2017 Jul; 55(6):609-612. PubMed ID: 28456449
[TBL] [Abstract][Full Text] [Related]
38. Systematic evaluation of salivary gland damage following I-131 therapy in differentiated thyroid cancer patients by quantitative scintigraphy and clinical follow-up.
Wu JQ; Feng HJ; Ouyang W; Sun YG; Chen P; Wang J; Xian JL; Huang LH
Nucl Med Commun; 2015 Aug; 36(8):819-26. PubMed ID: 25932534
[TBL] [Abstract][Full Text] [Related]
39. A randomized controlled trial for the use of thymus honey in decreasing salivary gland damage following radioiodine therapy for thyroid cancer: research protocol.
Charalambous A; Frangos S; Talias M
J Adv Nurs; 2014 Jul; 70(7):1663-71. PubMed ID: 24256334
[TBL] [Abstract][Full Text] [Related]
40. Salivary and lacrimal gland dysfunction after remnant ablation with radioactive iodine in patients with differentiated thyroid carcinoma prepared with recombinant human thyrotropin.
Rosario PW; Calsolari MR
Thyroid; 2013 May; 23(5):617-9. PubMed ID: 23136908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
